Free Trial

Stoke Therapeutics (STOK) SEC Filings & 10K Form

Stoke Therapeutics logo
$9.36 -0.14 (-1.47%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$9.30 -0.05 (-0.59%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Stoke Therapeutics SEC Filings

DateFilerForm TypeView
05/13/2025
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
5:41 PM
BlackRock, Inc. (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
04/15/2025
4:04 PM
BlackRock Portfolio Management LLC (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G
03/20/2025
5:15 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:16 PM
LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:17 PM
Leggett Thomas (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:18 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:19 PM
SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:05 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
5:12 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:05 PM
Stoke Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
3:07 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:08 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
3:31 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
3:36 PM
MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13G/A
01/07/2025
6:06 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:14 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:23 PM
Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
Form SCHEDULE 13D/A
12/27/2024
4:13 PM
Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
5:15 PM
Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:05 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:07 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:59 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4/A
12/10/2024
6:00 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:01 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:02 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:48 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:19 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:19 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:20 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:21 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:24 PM
BAKER BROS. ADVISORS LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G
11/14/2024
8:00 AM
Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G/A
11/05/2024
3:15 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:05 PM
Stoke Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:56 PM
Stoke Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:50 PM
Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
10/09/2024
3:16 PM
Stoke Therapeutics (Filer)
Form S-3ASR
09/23/2024
3:22 PM
Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
Form SC 13D/A
09/23/2024
3:23 PM
Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
4:23 PM
Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:20 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:05 AM
Stoke Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Stoke Therapeutics (Subject)
Form SC 13G
06/20/2024
11:15 PM
Stoke Therapeutics (Filer)
Form EFFECT
06/13/2024
3:06 PM
Stoke Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
3:42 PM
Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:32 PM
Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:35 PM
Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:37 PM
Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:39 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:41 PM
Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:27 PM
Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:29 PM
Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:16 PM
Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:18 PM
LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:19 PM
Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STOK) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners